|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Canada |
First Approval Date31 Dec 1951 |
/ Active, not recruitingEarly Phase 1 Effect on Pupil Size After One-time Administration of NV701 (Pilocarpine 1.25%) Vs. Vuity (Pilocarpine 1.25%)
Randomized contralateral eye study to evaluate the effect of one-time dosing of NV701 versus commercially available 1.25% pilocarpine solution on pupil size.
100 Clinical Results associated with Novus Vision LLC
0 Patents (Medical) associated with Novus Vision LLC
100 Deals associated with Novus Vision LLC
100 Translational Medicine associated with Novus Vision LLC